Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

Liver Physiology

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...

Cirrhosis II: Pathophysiology

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Zeitschrift fur Gastroenterologie·2022

Same author

Zeitschrift fur Gastroenterologie·2022

Same author

A case of autochthonous human Dirofilaria infection, Germany, March 2014.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2014

Same author

Hepatology - Guidelines on Parenteral Nutrition, Chapter 16.

German medical science : GMS e-journal·2010

Same author

ESPEN Guidelines on Enteral Nutrition: Liver disease.

Clinical nutrition (Edinburgh, Scotland)·2006

Same author

[Branched chain amino acids as oral supplements in liver cirrhosis].

Zeitschrift fur Gastroenterologie·2006

Search research articles

Related Experiment Video

Updated: May 11, 2026

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

Published on: October 21, 2017

[Nutrition and liver failure].

¹Klinik für Innere Medizin, Städtisches Klinikum Dessau, Auenweg 38, 06847, Dessau, Deutschland. mathias.plauth@klinikum-dessau.de

Medizinische Klinik, Intensivmedizin Und Notfallmedizin

|May 18, 2013

Summary

This summary is machine-generated.

Nutrition support for critically ill liver patients prioritizes nasoenteral tube feeding. Parenteral nutrition is used when enteral feeding is not feasible, with special attention to malnutrition and deficiencies in chronic liver disease.

More Related Videos

Extended 78% Hepatectomy in a Mouse Surgical Model

Extended 78% Hepatectomy in a Mouse Surgical Model

Published on: May 24, 2024

Related Experiment Videos

Last Updated: May 11, 2026

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

Published on: October 21, 2017

Extended 78% Hepatectomy in a Mouse Surgical Model

Extended 78% Hepatectomy in a Mouse Surgical Model

Published on: May 24, 2024

Area of Science:

Hepatology
Clinical Nutrition
Critical Care Medicine

Context:

Critically ill patients with liver disease require tailored nutritional strategies.
Nutritional support varies in importance depending on the subtype and duration of liver failure.
Protein malnutrition is prevalent in chronic liver disease, impacting prognosis.

Purpose:

To outline optimal nutrition support strategies for patients with acute and chronic liver disease.
To differentiate nutritional needs in hyperacute versus protracted liver failure.
To emphasize the importance of early nutritional intervention in chronic liver conditions.

Summary:

Nasoenteral tube feeding with standard formulas is the primary approach for liver patients.
Parenteral nutrition is reserved for cases where enteral nutrition is insufficient or not possible.
Enteral nutrition is recommended for chronic liver disease to address protein-energy malnutrition, while carefully managing refeeding syndrome and micronutrient deficiencies.

Impact:

Provides evidence-based guidelines for optimizing nutrition in liver disease patients.
Highlights the critical role of nutrition in improving outcomes for critically ill liver patients.
Informs clinical practice regarding the prevention and management of malnutrition and refeeding syndrome in hepatology.